Related by context. Frequent words. (Click for all words.) 64 human antibody therapeutics 60 human monoclonal antibody 56 IIa trial 55 product Alferon N 54 Sodium oxybate 54 immune modulating 53 PRT# 53 HGS ETR2 53 Plicera 53 Initiates Phase II 52 Belimumab 52 peripherally acting 52 PSMA ADC 52 Brentuximab vedotin 52 liposomal formulation 52 clinically contraindicated 52 insure Merchandise 52 immunomodulation 52 Anadys Form 51 recurrent glioblastoma 51 diagnosed glioblastoma multiforme 51 humanized antibody 51 Allovectin 7 ® 51 deforolimus 51 Panzem R NCD 51 SUCCEED trial 51 diagnosed GBM 50 Receives Orphan Drug Designation 50 ® bortezomib 50 Trofex 50 HOW LONG WAS 49 HuMax EGFr 49 granted Fast Track 49 MKC# 49 desvenlafaxine succinate 49 addressing idiopathic pulmonary 49 FDA Accepts 49 anti fibrotic 49 MERLIN TIMI 48 SOM# 48 rindopepimut 48 anti leukemic 48 glycosylated 48 fibrosis IPF 48 efficacy endpoint 48 UsiRNAs 48 CD#.# DOES NOT ENDORSE 48 Genz # 48 Secondary endpoints include 48 Rosetta Annual Report 48 refractory CLL 48 Reproductions must 47 peripheral sensory neuropathy 47 Study Evaluating 47 mucosal healing 47 Gleevec resistant 47 RH1 47 APTIVUS r 47 pharmacokinetic PK 47 Valortim ® 47 TRISCUIT crackers 47 HBeAg positive 47 TAXUS Express Stent 47 lung metastasis 46 CCR5 antagonist 46 preclinical efficacy 46 PDGFR 46 Pharmacodynamic 46 hepatocellular 46 DOXIL 46 Phase 1b trial 46 developing biomedical countermeasures 46 By RICK KRETZSCHMAR 46 RNAi compounds 46 accretive thereafter 46 UVIDEM 46 By BEVERLY CORBELL 46 Aerosurf 46 histologically confirmed 46 multicenter Phase 46 antiproliferative 46 TOLAMBA 46 Ustekinumab 46 QTinno 46 Combination therapy 46 plus MTX 46 hepatitis C lupus 46 administered subcutaneously 46 Secondary endpoints included 46 PREZISTA r 45 I. Item 1A 45 CCX# 45 EpiCept periodic reports 45 anti angiogenic drugs 45 evaluable 45 R bortezomib 45 Tesamorelin 45 ASONEP 45 ATL# [001] 45 Augment Injectable 45 Secondary endpoints